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Methods 
 
Cognitive test 
Processing speed is accessed using a two choices reaction time task where participants 
respond to one of two targets on the computer screen. After two practice trials, 60 stimuli are 
presented. Two memory tests are undertaken. For episodic memory, a Paired Associates 
learning test is done where seven stimuli are presented in series in boxes at different locations 
presented peripherally on the screen. The stimuli are then hidden. Each stimulus is then 
presented centrally and the box in which it was initially presented must be identified. For 
working memory, a digit span test is carried out where an increasing number of digits are 
presented and have to be recalled. Beginning with one digit, a further digit is added with each 
trial until the participant gives an incorrect response. Attention is accessed using a Stroop test 
where words describing colours are presented for selection according to whether or not the 
font colour matches the semantic meaning. There are two conditions each with 20 stimuli. 
Executive function, the mental capacity to control and purposefully apply one's own mental 
skills, is assessed by a Fluid IQ test. A verbal and numeric reasoning test is undertaken that 
presents twelve items that gradually increase in difficulty. 
 
Repeatability of health screening data 
A small number of participants is invited for a second screening in order to evaluate 
the repeatability of the measurements. We evaluated the concordance between screening 
results obtained 3.4 months apart on average (minimum: 0.9 month; maximum: 6 months) in 
310 participants (Supplementary table 6). Paired t-tests were used to assess differences 
between the two screenings. Intra-subject agreement was analyzed via Intraclass Correlation 
Coefficient (ICC) adjusted for the number of hours since eating and the number of days 
between the two screenings (Portney L, Watkins M. Foundations of Clinical Research 
Applications to Practice. 2000). 
  Systolic and diastolic blood pressures decreased significantly between the two 
screenings (-3.4 mmHg and -2.4 mmHg respectively), as well as weight (-508g). Other 
significant decreases were observed for apolipoprotein B, C reactive protein, basophil count 
and mean cell haemoglobin although differences were small. Most variables had strong or 
almost perfect agreement between the two screenings (ICC≥0.7). Otherwise, moderate 
agreement (ICC≥0.5) was observed for heart rate (Omron), stiffness index estimated from 
Pulse Trace, urea, HbA1C, C-reactive protein, C-peptide, fibrinogen, prothrombin time, white 
blood cell count and neutrophils count, and fair agreement (ICC≥0.3) was observed for non 
fasting glucose, mean cell haemoglobin concentration, basophils, large unstained cells counts 
and pulse wave velocity estimated from Vicorder.  
 
 
 
Supplementary Table 1 Response rate and comparison of participant age and sex distributions with the original target population by force 
   
Force statistics  Database statistics 
 
Start date  
of Phase 1 
End date  
of Phase 2 
Total 
number of 
employees 
a
 
% of 
men 
b
 
Average 
age 
b
 
 
Total 
number of 
participants 
% of 
men 
Average 
age 
Response  
rate % 
Forces completed 
c
 
    
 
    Cheshire Constabulary *
†
 Jun-06 Apr-08 3,606 60 40  1,945 62 39 54 
Devon & Cornwall Police Nov-09 Jul-12 6,728 75 41  3,222 61 42 48 
Dyfed Powys Police *
†
 Mar-07 Jan-09 2,139 61 41  1,122 59 41 52 
Essex Police *
†
 Sep-06 Mar-09 5,881 59 39  3,186 57 39 54 
Gwent Police *
†
 Aug-06 Jun-08 2,430 59 41  1,471 61 40 61 
Hertfordshire Constabulary *
†
 Nov-09 May-12 3,890 66 39  1706 56 40 44 
Lancashire Constabulary 
d
* Apr-04 Dec-05 5,452 - -  2,274 63 39 42 
Leicestershire Constabulary *
†
 Dec-05 Mar-07 3,497 60 40  1,653 69 40 47 
Lothian & Borders Police Oct-07 Oct-10 4,473 65 40  2,259 66 40 51 
Merseyside Police 
†
 Jul-08 Oct-11 7,298 60 39  3,233 61 40 44 
Norfolk Constabulary *
†
 Feb-08 Aug-10 3,203 59 41  1,752 58 41 55 
North Wales Police * Sep-07 Dec-09 2,590 57 41  1,455 58 40 56 
South Wales Police *
†
 Nov-04 Jun-08 5,055 60 40  3,757 64 39 74 
Staffordshire Police *
†
 May-06 Oct-07 3,940 59 40  1,877 61 40 48 
Strathclyde Police *
†
 May-08 Nov-10 9,901 63 37  3,367 71 40 34 
Suffolk Constabulary *
†
 May-07 Jul-10 2,288 59 40  1,207 61 41 53 
Tayside Police 
†
 Jun-07 Jun-2011 1,823 - -  926 64 41 51 
Warwickshire Police *
†
 Apr-08 Aug-09 1,671 59 41  894 61 42 54 
West Midlands Police 
d
 Apr-04 Jan-06 11,939 - -  698 71 37 6 
 
     
 
    
Total forces completed Apr-04 Jul-12 87,804 - -  38,004 62 40 43 
 
     
 
    
Forces ongoing 
e
 
    
 
    
Central Scotland Police Jun-10 - 1,209 - -  178 72 38 15 
Dorset Police Apr-12 - 2,566 - -  721 57 42 28 
Dumfries & Galloway Police *
†
 Sep-06 - 774 - -  182 65 39 24 
Fife Constabulary Jan-09 - 1,639 - -  131 71 39 8 
Grampian Police * Jan-08 - 2,320 - -  807 64 41 35 
Lincolnshire Police 
†
 Jul-07 - 2,486 59 40  366 66 40 15 
Metropolitan Police Service Oct-11 - 53,196 - -  980 69 42 2 
Northern Constabulary * Oct-07 - 1,113 - -  172 73 41 15 
Serious organized crime agency 
f†
 Jan-07 - - - -  292 87 42 - 
Serious organized crime agency 
Scotland 
f
 
Jan-07 - - - -  99 88 41 - 
Other forces 
g
 - - - - -  180 58 43 - 
 
     
 
    
Total forces ongoing 
h
 Sep-06 - - - -  4,108 67 41 5 
 
     
 
    
Total enrolment 
h
 - - - - -  42,112 63 40 27 
* 
This forces provides objective Airwave usage records at 31/12/2012
 
† 
this force provides sickness absence data at 31/12/2012 
a
 Total number of police employees obtained from the police directories of the year of completion of  enrolment 
b
 Statistics obtained from each force, not presented if not provided  
c
 Police forces where the recruitment is complete. Number of police employees obtained from the police directories of the year when Phase 2 ended. 
d 
Forces where the pilots were conducted 
e
 Police forces which only started Phase 1 or Phase 2 at by 31/12/ 2012. Numbers of police employees obtained from the 2012 police directories were used 
to estimate response rate to date 
f 
Nation-wide police forces with open enrolment. Unknown number of police employees 
g
 Force unknown or participants not enrolled through their own force, i.e. when the health screening location was convenient for police employees from 
other forces 
h 
Response rate calculated excluding Serious Organized Crime agencies (since their numbers of employees are unknown) and Other forces (since no 
enrolment was set up in those forces). 
 
 
Supplementary Table 2 Available information for Airwave Health Monitoring Study members 
 
Questionnaires 
a
 Health Screening Other 
• Socio-
demographic 
characteris-
tics 
• Sex 
• Age 
• Ethnicity  
• Education  
• Income   
• Marital status  
• Household composition  
 
• Nurse 
interview 
• Sex 
• Age 
• Medical history 
• Medications 
• Smoking status 
• Alcohol consumption 
• Fasting time 
• TETRA 
usage 
records 
• Provided by Home 
Office for some of the 
forces 
• Work 
environment 
• Night shift  
• Rank and role 
• Seniority 
• Job strain (selected items from the 
Karasek Job content Questionnaire 
b
)
 
• Overtime  
 
• Anthropo-
metry 
• Weight 
• Height 
• Sitting height 
• Body impedance 
• Waist circumference 
• Hip circumference 
• 7 day 
TETRA 
usage diary 
• Completed by a sub-
sample of participants 
before the health 
screening 
• TETRA 
usage 
• Typical usage for each radio type 
and mode  
• Frequency and duration of calls 
during the last shift for each radio 
type  
• Percentage of usage for the pooled 
and desk mounted radios  
• Position of radio 
• Associated symptoms 
• Duration of old analogue radio 
usage  
 
• Cardiovas-
cular system 
• Sitting systolic and diastolic 
blood pressures 
• Standing systolic and diastolic 
blood pressures 
• Arterial stiffness i 
• Heart rate i 
• ECG, including Minnesota 
Codes 
 
• 7 day food 
diary 
• Completed by a sub-
sample of participants 
before the health  
screening 
• Lung 
function 
 
• Spirometry j 
 
  
• Mobile 
phone usage 
• Start date  
• Duration of calls during the last 24h 
• Haemato-
logy 
• Haemoglobin  
• Haematocrit  
• Cancer / 
Death 
• Obtained from MRIS 
and GROS  
• Hands-free equipment usage 
• Position of the phone 
• Associated symptoms 
 
• Mean red cell volume 
• Mean cell haemoglobin 
• Mean cell haemoglobin 
concentration  
• Neutrophils  
• Lymphocytes  
• Monocytes  
• Eosinophils  
• Basophils 
• Large unstained cells Count 
• Platelets 
 
• Lifestyle • Tobacco consumption 
• Alcohol consumption 
• Short International physical activity 
questionnaire (IPAC) 
c
 
• 10 items Food Frequency 
questionnaire  
 
• Blood 
biochemistry 
• Total Protein j 
• Albumin j 
• Alanine aminotransferase  
  
j
 
• Alkaline phosphatise j  
• Total bilirubin j 
• Calcium j 
• Sodium j 
• Potassium j 
• Urea  
• Creatinine  
• Total cholesterol  
• High density lipoprotein 
• Glucose k 
• Gamma glutamyl  transferase 
• Apolipoprotein A and B  
• Glycosylated haemoglobin 
• High sensitivity C-reactive 
protein 
k
 
• C-peptide k 
• Hospita-
lisations 
• Hospital Episode 
Statistics (HES) 
records 
  
• Health • Menopausal status 
• Use of contraceptive pill and 
hormone replacement therapy 
• Reproduction and birth history  
• Description of headache  
• Description of pain in the chest 
(selected items from Rose et al
 d
)  
• Medical history 
• Family history 
• Fatigue (Short Checklist Individual 
Strength 
e
)  
• Hours of sleep 
• Depression (Personal Health 
  
Questionnaire Depression Scale 
PHQ-9 
f
)
 
 
• Anxiety (subscale of the Hospital 
anxiety and depression scale 
g
)
 
 
• Brief screening instrument for Post 
Traumatic Stress Disorder 
h
 
• Sickness leave/GP consultation 
 
• Coagula-
tion  
• Fibrinogen 
• Prothrombin time 
 
• Sickness 
absence 
 
• Provided by some of 
the forces’ human 
resources departments 
• Genoty-
ping 
• Illumina Infinium Human 
Exome-12v1-1 BeadChip
l
 
• Cognitive 
tests 
• Memory 
• Processing speed 
• Attention  
• Executive function 
 
a
 Includes questions asked in enrolment questionnaire or browser questionnaire or both. The content and format of the enrolment questionnaire 
evolved during the pilot study (until mid-2006), and was modified more recently to capture the different working practices of particular forces.  
b
 
Available at http://www.jcqcenter.org c Available at http://www.ipaq.ki.se/  
d
 Rose G et al. British Journal of Preventive and Social Medicine, 
1977, 31, 42-48 
e 
Vercoulen J et al. Journal of Psychosomatic Research, 38(5):383–392, 1994. f Kroenke K et al. Journal of General Internal 
Medicine, 16(9):606–613, 2001 g Zigmond AS et al. Acta Psychiatrica Scandinavica, 1983 Jun;67(6):361-70 h Brewin CR et al. British Journal 
of Psychiatry, 2002, 181:158-162 
i 
With Vicorder and Pulse Trace devices 
j 
Available between June 2004 and October 2006 only 
k
Available 
from October 2006 only. 
l
 Performed in 2,016 participants. MRIS: Medical Research Information Service; GROS: General Register Office for 
Scotland 
 
 
  
Supplementary Table 3 Methods of clinical measurements 
  Condition Kit 
Number of 
measurements 
a
 
Exclusion 
Sitting blood pressure (BP) 
b
 Seated Omron HEM 705-CP digital BP monitor (Omron 
Health Care) and either regular or large size cuff 
3 (30sc apart) - 
Standing BP Standing Omron HEM 705-CP digital BP monitor (Omron 
Health Care) and either regular or large size cuff 
3 (30sc apart) Non-diabetic 
participants 
Heart rate Seated Omron HEM 705-CP digital BP monitor (Omron 
Health Care) and either regular or large size cuff 
3 (30sc apart) - 
Heart rate Lying (upper torso lying 
flat, or at an angle of not 
more than 30°) 
Pulse Trace (Micro Medical) 3 - 
Heart rate Lying (upper torso lying 
flat, or at an angle of not 
more than 30°) 
Vicorder device (Skidmore Medical)  1 - 
Height Light clothing, 
no shoes or socks 
Marsden H226 portable stadiometer 2 - 
Sitting height Light clothing, 
no shoes or socks 
Marsden H226 portable stadiometer 2 - 
Weight Light clothing, 
no shoes or socks 
Marsden digital weighing scale 2 - 
Body composition 
c
 Light clothing, 
no shoes or socks 
Tanita BC-418MA body composition analyser 1 Pregnant women, 
participants with a 
pacemaker or 
metal implant 
Waist circumference 
d
 Lying flat Wessex-finger/joint measure tape (Seca 201, Seca) 2 Pregnant women 
Hip circumference 
e
 Lying flat Wessex-finger/joint measure tape (Seca 201, Seca) 2 Pregnant women 
Electrocardiogram (ECG) 
f
 Lying (upper torso lying 
flat, or at an angle of not 
more than 30°) 
12 lead ECG electrocardiograph (Burdick 
Eclipse/Atria6100) 
1 (10sec) - 
Arterial stiffness  
(stiffness index) 
g
 
Lying (upper torso lying 
flat, or at an angle of not 
more than 30°) 
Pulse Trace (Micro Medical) 3 - 
Arterial stiffness (brachial-
femoral pulse wave velocity) 
h
 
Lying (upper torso lying 
flat, or at an angle of not 
more than 30°) 
Vicorder device (Skidmore Medical)  1 - 
Spirometry 
i
 Seated Spiro USB (Micro Medical) 3 - 
a
 When several measurements were taken, the average was used 
b
 If the average BP reading exceeds either 180 mmHg systolic or 110 mmHg diastolic, the participant is advised to visit his or her general practitioner  
c
 To account for the weight of clothes, 2kg is subtracted from the weight measured by the Tanita machine 
d
 Distance between the lower rib margin and the iliac crest in the mid-axillary line  
e
 Measured at the point yielding the maximum circumference  
f
 At the end of each day the ECGs are transferred to CARE (Computer Assisted Reporting of ECG) at the University of Glasgow Core ECG laboratory. 
ECGs are interpreted by a cardiologist, who returns results in the form of Minnesota Codes (Prineas R, Crow R, Blackburn H. The Minnesota Code 
Manual of Electrocardiographic Findings. Littleton, MA: John Wright-PSG Inc. 1982) and a summary that may recommend referral of the participant to 
his/her general practitioner. Where indicated, urgent referral to a cardiologist may be recommended. 
g
 A digital volume pulse is obtained using an infrared light-transmitting unit placed on the index finger of the participant. The time between the systolic 
peak and the diastolic peak of the waveform (Δt) is used to calculate the stiffness index (SI(m/sec)=height of the participant/Δt) (Millasseau SC et al. 
Am J Hypertens 2003; 16(6): 467-72). PT1000 was used from the study launch in 2004 until 2009, and then PT2000. 
h
 Vicorder is used since October 2008. First, a cuff is placed around the participant's upper arm, and a cuff is placed around the participant’s upper thigh. 
Both cuffs are inflated simultaneously and the corresponding oscillometric signals from each site are used to calculate the transit time. The distance 
between the two cuffs is measured by the nurse using a Wessex-finger/joint measure tape and recorded in the Vicorder software to calculate the 
brachial-femoral pulse wave velocity. In a sub-sample of participants (8.4%), brachial-ankle pulse wave velocity was measured rather than brachial-
femoral pulse wave velocity. 
i
 Performed from June 2004 to October 2006 only  
 
  
Supplementary Table 4 Blood measurements 
  Sample type Assay 
Haematology tests  Whole blood EDTA sample  Pilot study: H1E analyser (Technicon) 
Main study: Bayer ADVIA 2120 analyser (Bayer 
HealthCare) 
Coagulation tests  Sodium citrate plasma Pilot study: ACL 300 analyser (Beckman Coulter) 
Main study: ACL 8000 analyser (Beckman Coulter) 
Biochemistry tests  Serum sample that has been spun on site at the clinics Pilot study: Cobas Mira Plus analyser (Roche)  
Main study: IL 650 analyser (Instrumentation Laboratory) 
HbA1C Whole EDTA blood sample Pilot study: Cobas Mira Plus analyser (Roche)  
Main study: IL 650 analyser (Instrumentation Laboratory) 
Glucose Fluoride/oxalate sample tube Pilot study: Cobas Mira Plus analyser (Roche)  
Main study: IL 650 analyser (Instrumentation Laboratory) 
C-peptide Serum sample that has been spun on site at the clinics DTX 800 Eliza Plate Reader (Beckman Coulter) 
Genotyping EDTA Buffy coats Illumina Infinium HumanExome-12v1-1 BeadChip Array 
 
 
Supplementary Table 5 Biological material stored in the Airwave Health Monitoring Study 
a
 
 Quantity 
collected 
(ml) 
Storage (number of 2ml cryovials) 
 Plasma Serum RBC 
Buffy 
coat 
Whole 
blood 
Total 
Blood samples        
    EDTA 9 2 - 2 1 - 5 
    SST 5 - 3 - - - 3 
    Sodium citrate 3.5 1 - - 1 - 2 
    Lithium heparin 9 2 - - 1 - 3 
    ACD 6 - - - - 2 2 
Urine samples 12 - - - - - 5 
a
 The volume of sample stored is not fixed for each tube as it depends on the volume 
collected and amount utilized for analysis. As an approximation, 1.5 ml of plasma/serum, 0.7 
ml of buffy coat and up to 2 ml of RBC are stored per cryovial. All the storage is in 2ml 
cryovials. RBC: Red Blood Cell; EDTA: Ethylenediaminetetraacetic acid; SST: Serum-
separating tubes; ACD: acid-citrate-dextrose 
 
  
Supplementary Table 6 Repeatability of the clinical and biological measurements between first screening and repeat screening   
 
n 
First screening 
Repeat 
screening P 
a
 ICC (95% CI) 
b
 
 
Mean SD Mean SD 
Clinical Variables 
            Systolic blood pressure (mmHg) 310 130.3 14.5 126.9 13.8 <.0001 0.70 (0.64, 0.75) 
     Diastolic blood pressure (mmHg) 310 79.4 9.7 76.9 9.6 <.0001 0.74 (0.69, 0.79) 
     Omron heart rate (beat/mn) 310 69.9 10.9 68.8 10.2 0.03 0.63 (0.56, 0.69) 
     Stiffness index 
c
 210 8.0 2.3 7.9 2.2 0.47 0.66 (0.58, 0.74) 
     Brachial-femoral pulse wave velocity (m/s)
 c
 113 11.9 3.0 11.7 2.7 0.44 0.41 (0.27, 0.57) 
     Weight (kg) 310 82.3 15.6 81.7 15.4 0.008 0.98 (0.97, 0.98) 
     Height (cm) 310 173.2 9.2 173.2 9.1 0.69 1.00 (0.99, 1.00) 
     Sitting height (cm) 275 90.3 4.4 90.3 4.2 0.67 0.92 (0.90, 0.94) 
     Waist Girth (cm) 306 89.4 11.4 88.7 11.1 0.03 0.89 (0.86, 0.91) 
     Hip Girth (cm) 306 103.3 7.9 103.2 8.1 0.80 0.82 (0.79, 0.86) 
     Body impedance  263 595.6 84.5 592.1 84.2 0.03 0.95 (0.94, 0.96) 
     Fat percentage (%) 263 28.4 8.2 27.8 8.2 0.008 0.92 (0.90,0.94) 
Blood biochemistry        
     Urea (mmol/l) 303 5.0 1.2 5.0 1.2 0.59 0.61 (0.53, 0.68) 
     Creatinine (μmol/l) 303 90.8 13.0 91.3 12.1 0.34 0.74 (0.68, 0.79) 
     Total cholesterol (mmol/l) 303 5.4 1.1 5.4 1.0 0.96 0.78 (0.73, 0.82) 
     High density lipoprotein (mmol/l) 303 1.52 0.37 1.52 0.37 0.67 0.87 (0.84, 0.90) 
     Glucose (mmol/l) 265 5.4 0.9 5.4 1.0 0.60 0.29 (0.19, 0.41) 
     Gamma glutamyl transferase (u/l) 
c
 303 28.9 19.6 29.3 20.0 0.73 0.82 (0.78, 0.86) 
     Apoliprotein A (g/l) 302 1.37 0.22 1.38 0.21 0.60 0.72 (0.66, 0.77) 
     Apolipoprotein B (g/l) 303 0.95 0.25 0.93 0.25 0.04 0.83 (0.79, 0.86) 
     HBA1C (%) 302 5.6 0.5 5.6 0.5 0.66 0.64 (0.57, 0.71) 
     C reactive protein (mg/l) 
c
 269 2.1 3.2 1.9 2.8 0.03 0.65 (0.58, 0.72) 
     C Peptide (pmol/l) 
c
 269 1100.8 731.8 1142.0 861.5 0.77 0.54 (0.46, 0.63) 
Coagulation        
     Fibrinogen (g/l) 299 3.9 0.9 3.8 0.9 0.16 0.62 (0.54, 0.68) 
     Protombin time (s) 299 13.6 1.0 13.6 1.1 0.48 0.55 (0.47, 0.63) 
Haematology        
     Red blood cell count (10
6/μl) 304 4.6 0.4 4.6 0.4 0.85 0.83 (0.79, 0.86) 
     White blood cell count (10³/μl) 304 6.5 1.7 6.5 1.6 0.38 0.65 (0.58, 0.71) 
     Haemoglobin (g/dl) 304 14.0 1.3 14.0 1.3 0.10 0.83 (0.79, 0.86) 
     Haematocrit (%) 303 41.2 3.7 41.0 3.7 0.36 0.75 (0.69, 0.79) 
     Mean red cell volume (fL) 304 89.0 4.3 88.8 4.3 0.18 0.83 (0.80, 0.87) 
     Mean cell haemoglobin (pg) 304 30.4 1.6 30.2 1.6 0.003 0.86 (0.83, 0.89) 
     Mean cell haemoglobin concentration (g/dl) 304 34.1 1.1 34.0 1.2 0.20 0.45 (0.37, 0.54) 
     Platelets (10³/μl) 304 270.0 58.9 268.0 57.1 0.35 0.79 (0.75, 0.83) 
Differential white cell counts        
     Neutrophils count (10³/μl) c 304 3.9 1.3 4.0 1.3 0.36 0.61 (0.54, 0.68) 
     Monocytes count (10³/μl) 304 0.38 0.15 0.39 0.18 0.22 0.77 (0.72, 0.81) 
     Eosinophils count (10³/μl) c 304 0.19 0.15 0.19 0.13 0.11 0.74 (0.69, 0.79) 
     Lymphocytes count (10³/μl) 304 1.82 0.50 1.83 0.50 0.48 0.76 (0.71, 0.80) 
     Basophils count (10³/μl) c 298 0.05 0.03 0.04 0.03 0.04 0.45 (0.36, 0.54) 
     Large unstained cells count (10³/μl) 267 0.11 0.04 0.11 0.04 0.82 0.49 (0.40, 0.58) 
a
 P value from paired t-test  
b
 ICC: Intraclass Correlation Coefficient; adjusted for the number of hours since eating and the number of days between the screenings; 
estimated using the %icc9 macro of SAS (Hertzmark E and Spiegelman D, 2010) 
c
 Variable log-transformed for the estimation of the ICC and the paired t-test 
 
 
  
